ODT articles & resources on Made-in-China.com

The USFDA Has Cleared Actavis's ANDA for Lamotrigine Orally Disintegrating Tablets

Jul 17, 2013

The USFDA has cleared Actavis' abbreviated new drug application (ANDA) for Lamotrigine orally disintegrating tablets, 25mg, 50mg, 100mg and 200mg. A generic version of GlaxoSmithKline's Lamictal ODT, the antiepileptic drug is indicated ...

Tags: Orally Disintegrating Tablets, Medicine

Open-Xchange Plans to Launch an Open-Source, Browser-Based Productivity Suite

Mar 20, 2013

Collaboration software vendor Open-Xchange plans to launch an open-source, browser-based productivity suite called OX Documents. The first application for the suite is OX Text, an in-browser word processing tool with editing capabilities ...

Tags: Computer Products, OX Documents, software

FDA Has Accepted Neos Therapeutics' New Drug Application (NDA) 505(b)(2) Filing for NT0202

Mar 15, 2013

The US Food and Drug Administration (FDA) has accepted Neos Therapeutics' new drug application (NDA) 505(b)(2) filing for NT0202, an extended release (XR) orally disintegrating tablet (ODT) formulation of Amphetamine Polistirex. The ...

Tags: FDA, ADHD Drug, Drug

Dr. Reddy's Laboratories Has Received The FDA Approval and Introduced Desloratadine ODT

Jan 29, 2013

Dr. Reddy's Laboratories has received the FDA approval and introduced Desloratadine orally disintegrating tablets (ODT) in 2.5mg and 5mg strengths in the US. Desloratadine ODT is a generic equivalent to Clarinex Reditabs (desloratadine), ...

Tags: Desloratadine ODT, ODT, dose

Kaspersky Researchers Started Investigating The Ongoing Operation

Jan 16, 2013

Unidentified attackers stole sensitive information from hundreds of diplomatic, government, research and military organizations from around the world as part of a newly uncovered cyberespionage campaign that started nearly six years ago. ...

Tags: attackers, sensitive information, cyberespionage campaign

Mylan Has Signed a Settlement and License Agreements with Shionogi and CIMA Labs

Dec 7, 2012

Mylan has signed a settlement and license agreements with Shionogi and CIMA Labs regarding Prednisolone sodium phosphate orally disintegrating tablets (ODT), known generically as Orapred ODT. Mylan said that following the settlement ...

Tags: ODT, orally disintegrating tablets, orapred ODT

Akrimax Pharmaceuticals Introduced Suprenza ODT for The Management of Exogenous Obesity

Nov 30, 2012

Akrimax Pharmaceuticals has introduced Suprenza (phentermine HCl) orally disintegrating tablets (ODT) for the management of exogenous obesity. The company has launched Suprenza ODT in 15mg and 30mg dosage strengths. Suprenza is ...

Tags: pharceumatical product, obesity drugs, clinical research

Catalent Has Started Supplying Its Antipsychotic Drug

Nov 28, 2012

Catalent has started supplying its antipsychotic drug, Abilify, an orally disintegrating tablet (ODT) to Otsuka Pharmaceutical. Abilify ODT, which utilizes Catalent's Zydis fast dissolve drug delivery technology, is designed to improve ...

Tags: Catalent, Abilify Antipsychotic Drug, Otsuka Pharma, antipsychotic drug

ODT

Related Products